Treatment Options for Muscle Pain
For acute muscle pain from strains, sprains, or soft tissue injuries, topical NSAIDs with or without menthol gel should be your first-line treatment, offering superior pain relief, improved function, and high patient satisfaction compared to other options. 1
First-Line Therapy for Acute Musculoskeletal Pain
Topical NSAIDs are strongly recommended as first-line therapy based on moderate-certainty evidence from the American College of Physicians and American Academy of Family Physicians 2020 guidelines. 1
Specific Topical NSAID Formulations with Proven Efficacy:
- Diclofenac Emulgel: Most effective option with 78% achieving pain relief vs 20% with placebo (NNT 1.8) at 7 days 2
- Ketoprofen gel: 72% pain relief vs 33% placebo (NNT 2.5) 2
- Diclofenac plasters: 88% relief vs 57% placebo (NNT 3.2) 2
- Topical NSAIDs with menthol gel: Reduced pain by 1.68 cm on 10-cm scale at <2 hours 1
Key advantage: Topical NSAIDs provide high treatment satisfaction (OR 5.20) and have systemic adverse event rates (4.3%) no greater than placebo (4.6%) in acute pain. 1, 2
Second-Line Pharmacologic Options
Oral Medications (Conditional Recommendation):
- Oral NSAIDs: Reduce pain by 0.99 cm on 10-cm VAS at 1-7 days, improve physical function (moderate-certainty evidence) 1
- Acetaminophen: Reduces pain by 1.07 cm at 1-7 days (moderate-certainty evidence) 1
- Tramadol: May be considered for up to 3 months specifically for osteoarthritis-related muscle pain 1
Important caveat: Oral NSAIDs carry gastrointestinal and cardiovascular risks; limit use to patients without coronary artery disease risk factors. 1
Heat-Based Topical Treatments
Capsaicin Cream (Heat-Producing Agent):
Capsaicin cream has limited and inconsistent evidence for muscle pain, with better data for neuropathic conditions rather than musculoskeletal pain. 3, 4
- FDA-approved indication: Temporarily relieves minor aches and pains of muscles and joints from simple backache, arthritis, strains, and sprains 3
- Low-dose capsaicin (0.075%): NNT of 6.6 for any pain relief over 6-8 weeks, but this data is primarily from neuropathic pain studies 5
- High-dose capsaicin (8%): More effective for neuropathic pain (postherpetic neuralgia) than musculoskeletal conditions 4, 6
- Adverse effects: Local burning and hyperemia occur in 85% of patients, though typically mild and transient (NNH 2.6 for local reactions) 6, 5
Clinical reality: While capsaicin is marketed for muscle pain, the evidence supporting topical NSAIDs is substantially stronger for acute musculoskeletal injuries. 1, 2
Non-Pharmacologic Options (Conditional Recommendation):
- Specific acupressure: Reduces pain by 2.09 cm at 1-7 days and improves physical function (moderate-certainty evidence) 1
- TENS (Transcutaneous Electrical Nerve Stimulation): Reduces pain by 1.18 cm at 1-7 days (low-certainty evidence) 1
- Massage therapy: Reduces pain by 0.70 cm at <2 hours (moderate-certainty evidence) 1
What to Avoid:
Opioids (including tramadol for acute injuries) are NOT recommended for acute non-low back musculoskeletal injuries due to low-certainty evidence of benefit and significant risks of misuse, addiction, respiratory depression, and cognitive impairment. 1
Chronic Musculoskeletal Pain Considerations:
For chronic conditions (>4 weeks) like osteoarthritis:
- Topical diclofenac: 60% achieve relief vs 50% placebo over 6-12 weeks (NNT 9.8) 2
- Topical ketoprofen: 63% relief vs 48% placebo (NNT 6.9) 2
- Acetaminophen and NSAIDs: Remain first-line for chronic musculoskeletal pain 1
Critical formulation note: The exact formulation matters significantly—Diclofenac Emulgel specifically outperforms other diclofenac formulations in acute pain. 2